Will Lewis

Will Lewis is an accomplished executive with extensive leadership experience in the pharmaceutical and biotechnology sectors. Currently serving as the Chair of the Board of Directors at NewAmsterdam Pharma Corporation, Will Lewis has held various prominent positions, including Chairman and Chief Executive Officer at Insmed Incorporated and Board Chair at Adrestia Therapeutics. Previous roles include Chairperson of the Board at BioNJ and a Member of the Board of Directors at Helix Acquisition Corp. Will Lewis began their career in governance as a Board Member at uniQure. Educational credentials include a Juris Doctor (JD) and a Master of Business Administration (MBA) from Case Western Reserve University, alongside a Bachelor of Arts (BA) from Oberlin College and a high school diploma from Hawken School.